Vertex Pharmaceuticals Incorporated
Nasdaq VERX · King Of Prussia, PA
Works in Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Neurology · Oncology · Renal & urogenital · Respiratory · Women's health
Vertex Pharmaceuticals Incorporated is a clinical trial sponsor based in King Of Prussia, PA, listed as Nasdaq VERX. It has 32 active clinical trials with 6,994 planned participants, across 11 therapeutic areas. Since 2021 it has completed 101 trials and stopped 4 early. Its FDA record on file shows 1 inspection.
Trial track record · since 2021
FDA record
Recent FDA actions
Financials · Nasdaq VERX
Pipeline · 32 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
9 approved drug applications with a product on the market.
Questions about Vertex Pharmaceuticals Incorporated
No warning letter naming Vertex Pharmaceuticals Incorporated is on file. FDA has published 1 inspection classification naming it.
FDA has posted 1 inspection classification naming Vertex Pharmaceuticals Incorporated. The latest inspection ended on 2026-07-31 and was classified NAI (no action indicated). FDA posts a classification after its review, often months after the inspection ended.
Vertex Pharmaceuticals Incorporated is lead sponsor of 32 active clinical trials on ClinicalTrials.gov, with 6,994 planned participants, in Genetic & rare, GI & liver, Hematology, Immunology and other areas. Since 2021 it has completed 101 trials and stopped 4 early.
Vertex Pharmaceuticals Incorporated is based in King Of Prussia, PA and is listed as Nasdaq VERX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Vertex Pharmaceuticals Incorporated; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-30.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with Vertex Pharmaceuticals Incorporated.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.